Biologically active acylthioureas and their Ni(II) and Cu(II) Complexes: Structural, spectroscopic, anti-proliferative, nucleolytic and antimicrobial studies

Ebube E. Oyeka, Ilknur Babahan, Bernard Eboma, Kenechukwu J. Ifeanyieze, Obinna C. Okpareke, Esin P. Coban, Ali Özmen, Burak Coban, Mehran Aksel, Namık Özdemir, Tatiana V. Groutso, Jude I. Ayogu, Ufuk Yildiz, Mehmet Dinçer Bilgin, H. Halil Biyik, Briana R. Schrage, Christopher J. Ziegler, Jonnie N. Asegbeloyin

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The study investigated the effects of morpholine substituent and metal complexation on in vitro anticancer and antimicrobial activities of acylthioureas using two acylthiourea molecules that differ only by the presence of morpholine oxygen; N,N-diethyl-N′-(4-chlorobenzoyl)thiourea (CBDEA) and N-morpholine-N′-(4-chlorobenzoyl)thiourea (CBMOR), and their Ni(II) and Cu(II) complexes (NiCBDEA, CuCBDEA, NiCBMOR, CuCBMOR). All compounds were synthesized and characterized by physicochemical and spectroscopic studies. CBDEA, CuCBDEA, NiCBDEA, CBMOR, and NiCBMOR were structurally elucidated by single-crystal X-ray diffraction. The metal complexes were isolated as neutral four coordinate complexes of the form, ML2 (M: Ni(II), Cu(II), H.L.: CBDEA/CBMOR) in square-planar geometry. The compounds were screened for DNA binding/cleavage, antimicrobial activity, and anti-proliferative effects on human prostate cancer PC-3 and breast cancer MCF-7 cells. DNA binding interaction studies suggest that the metal complexes bind more strongly to the DNA compared to the ligands. The morpholine derivative CBMOR shows similar activity to CBDEA against PC-3 cell lines but twice as effective against MCF-3 cells at cell death and apoptotic levels. Anticancer activities were enhanced by complexation with Cu(II), as evident in CuCBMOR, which showed the optimal anticancer activity (IC50: 1.76 µM for MCF-7 and 1.97 µM for PC-3), comparable to known anticancer drug paclitaxel. The CuCBMOR apoptosis results show that the cancer cells die by apoptotic mechanisms (Apoptosis rate: 91.53 % in MCF-7 and 85.95 % in PC-3). In vitro screening of the compounds against seventeen bacteria and four yeast strains confirmed antimicrobial potency against more susceptible Gram-positive bacteria strains. The results of the study suggest that some of the compounds could be developed into novel antimicrobial and anticancer agents.

Original languageEnglish
Article number120590
JournalInorganica Chimica Acta
Volume528
DOIs
StatePublished - Dec 1 2021
Externally publishedYes

Funding

The authors are grateful to the Department of Chemistry, Akron University , for assistance with X-ray crystal structure determination of CBDEA and CBMOR, School of Chemical Sciences, University of Auckland, New Zealand for crystal data of NiCBDEA and CuCBDEA and Scientific Research Projects Unit of Ondokuz Mayıs University (Project No: PYO.FEN.1906.19.001), Turkey for NiCBMOR. Many thanks to National Centre for Energy Research and Development, University of Nigeria,Nsukka for infrastructural support.

FundersFunder number
CuCBDEA and Scientific Research Projects Unit of Ondokuz Mayıs UniversityPYO.FEN.1906.19.001
University of Akron
Department of Chemistry, University of York
University of Auckland

    Keywords

    • Anticancer
    • Antimicrobial
    • Breast cancer (MCF-7)
    • Complexes
    • DNA binding
    • Morpholine
    • Prostate cancer (PC-3)
    • Thiourea
    • X-ray diffraction

    Fingerprint

    Dive into the research topics of 'Biologically active acylthioureas and their Ni(II) and Cu(II) Complexes: Structural, spectroscopic, anti-proliferative, nucleolytic and antimicrobial studies'. Together they form a unique fingerprint.

    Cite this